¼¼°èÀÇ °¨¿°Áõ ´ëÃ¥ ½ÃÀå : ¿¹Ãø(2025-2030³â)
Global Infection Control Market - Forecasts from 2025 to 2030
»óǰÄÚµå : 1824210
¸®¼­Ä¡»ç : Knowledge Sourcing Intelligence
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 145 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,950 £Ü 5,681,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,550 £Ü 6,544,000
PDF (Multiple User License) help
PDF º¸°í¼­¸¦ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,996,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

°¨¿°Áõ ´ëÃ¥ ½ÃÀå ±Ô¸ð

°¨¿°Áõ ´ëÃ¥ ½ÃÀåÀº CAGR 4.25%·Î, 2025³â 504¾ï 1,100¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 620¾ï 6,300¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

°¨¿° °ü¸® ½ÃÀåÀº ƯÈ÷ º´¿ø ¹× ÀÇ·á½Ã¼³¿¡¼­ °¨¿° ¹× ¹ÙÀÌ·¯½º ÀüÆÄÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ °í¾ÈµÈ °üÇà°ú ÀýÂ÷¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº »ç¶÷ °£ Á¢ÃË, ¿À¿°µÈ Ç¥¸é, °ø±â °¨¿°À» ÅëÇØ ÀüÆÄµÇ´Â ¼¼±Õ°ú ¹ÙÀÌ·¯½º·Î ÀÎÇÑ Áúº´À» ¿¹¹æÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸¸ç, ȯÀÚÀÇ ¾ÈÀü°ú ½Ã¼³ °ü¸®¸¦ À§ÇÑ Áß¿äÇÑ ÀÇ·á ÀÎÇÁ¶ó¸¦ ´ëÇ¥ÇÕ´Ï´Ù.

½ÃÀå ±â¹Ý ¹× ÀÓ»óÀû ÀÇÀÇ

°¨¿°°ü¸® ½ÇõÀº ȯÀÚÀÇ ½Ã¼³ ü·ù Áß ¹ß»ýÇϸç ÀÇ·á ȯ°æÀÇ ÁÖ¿ä »ç¸Á¿øÀÎÀÎ º´¿ø³» °¨¿°(HAI)¿¡ ´ëÇÑ Áß¿äÇÑ ¿¹¹æÃ¥ÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ °¨¿°Àº º¸Åë Áø´Ü ½Ã¼ú Áß ÀÇ·á±â±âÀÇ °øµ¿ »ç¿ëÀ¸·Î ÀÎÇØ ¹ß»ýÇϸç, ÀΰøÈ£Èí±â °ü·Ã Æó·Å, Ä«Å×ÅÍ °ü·Ã ¿ä·Î°¨¿°, Áß½ÉÁ¤¸Æ°ü °ü·Ã Ç÷·ù°¨¿°, ¼ö¼úºÎÀ§ °¨¿° µîÀÇ º´Å¸¦ À¯¹ßÇÕ´Ï´Ù.

HAIÀÇ ¹ß»ýÀº ȯÀÚÀÇ ¸é¿ªÃ¼°è »óÅÂ, ½Ã¼³ÀÇ °¨¿°°ü¸® °üÇà, º´¿ø ȯ°æ³» °¨¿° ¿äÀÎÀÇ Á¸Àç¿¡ µû¶ó ´Þ¶óÁý´Ï´Ù. ȯÀÚÀÇ ³ªÀÌ¿Í ½Ã¼³¿¡¼­ÀÇ Àå±â ü·ù´Â °¨¿° À§Çè¿¡ Å©°Ô ±â¿©Çϸç, HAI¿Í °ü·ÃµÈ ÀϹÝÀûÀÎ ¼¼±ÕÀ¸·Î´Â ´ëÀå±Õ, MRSA, Ŭ·¹ºê½Ã¿¤¶ó, ´ëÀå±Õ, À屸±Õ, ½´µµ¸ð³ª½º ¼Ó µîÀÌ ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎ

º´¿ø³» °¨¿° ¿¹¹æ

ÀÇ·á½Ã¼³ÀÌ È¯ÀÚ °£ °¨¿°À» ¿¹¹æÇϱâ À§ÇØ ¸ê±Õ-¼Òµ¶À» ¿ì¼±ÀûÀ¸·Î ½Ç½ÃÇÔ¿¡ µû¶ó HAI ¹ß»ý·ü Áõ°¡°¡ ½ÃÀåÀÇ ±âº»ÀûÀÎ ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. °¡Àå ÈçÇÑ °¨¿°¿¡´Â Ç÷·ù°¨¿°, Æó·Å, ¿ä·Î°¨¿°, ¼ö¼úºÎÀ§ °¨¿° µîÀÌ ÀÖÀ¸¸ç, ±× Áß ¼ö¼úºÎÀ§ °¨¿°Àº ÀÔ¿ø±â°£ÀÇ Àå±âÈ­¿Í ±×¿¡ µû¸¥ Áø´Ü°Ë»ç·Î ÀÎÇØ °¡Àå Å« ºñ¿ë¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÀÇ·á½Ã¼³¿¡¼­´Â °¨¿° À§ÇèÀ» ÃÖ¼ÒÈ­Çϰí, ȯÀÚ ¿¹Èĸ¦ °³¼±Çϸç, °ü·Ã ÀÇ·á ºñ¿ëÀ» Àý°¨Çϱâ À§ÇØ Ã·´Ü Àåºñ¿Í ÀýÂ÷°¡ Æ÷ÇÔµÈ Á¾ÇÕÀûÀÎ ¸ê±Õ ÇÁ·ÎÅäÄÝÀ» ½ÃÇàÇϰí ÀÖ½À´Ï´Ù.

¼ö¼ú°ú Àα¸ µ¿Çâ

³ëÀÎ Àα¸ Áõ°¡¿Í ¸¸¼ºÁúȯÀÇ È®»ê¿¡ µû¸¥ ¼ö¼ú °Ç¼ö Áõ°¡°¡ Áö¼ÓÀûÀÎ ½ÃÀå ¼ö¿äÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. °í·ÉÀÚ Áý´ÜÀº °¨¿° °¨¼ö¼ºÀÌ ³ô±â ¶§¹®¿¡ Ãë¾àÇÑ È¯ÀÚ Áý´Ü¿¡ ´ëÇÑ °¨¿° ´ëÃ¥ °­È­ ¹× Ư¼öÇÑ ÇÁ·ÎÅäÄÝÀÌ ÇÊ¿äÇÕ´Ï´Ù.

±â¼ú ¹ßÀüÀÇ ÅëÇÕ

ÀüÀÚºö ¸ê±Õ°ú ¿¡Æ¿·»¿Á»çÀÌµå ¸ê±ÕÀÇ ÀçµµÀÔÀ» Æ÷ÇÔÇÑ ¸ê±Õ ÀåºñÀÇ ±â¼úÀû ¹ßÀüÀº È¿°ú¿Í È¿À²¼ºÀÇ Çâ»óÀ» ÅëÇØ ½ÃÀå È®´ë¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ» ÅëÇØ ÀÇ·á½Ã¼³Àº ÀÇ·á Àåºñ ¹× ½Ã¼³ Ç¥¸éÀÇ ´Ù¾çÇÑ ¸ê±Õ ¿ä°ÇÀ» ÃæÁ·½ÃŰ¸é¼­ º¸´Ù È¿°úÀûÀÎ °¨¿° ¿¹¹æ ÇÁ·ÎÅäÄÝÀ» ±¸ÇöÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù.

½ÃÀå ±¸ºÐ ¹× Ȱ¿ë ¿µ¿ª

½ÃÀå ¼¼ºÐÈ­¿¡´Â ÀÇ·á½Ã¼³, Á¦¾à ȸ»ç, ÀÇ·á±â±â Á¦Á¶¾÷ü¸¦ À§ÇÑ ¸ê±Õ ¼­ºñ½º, ±â±â Á¦Á¶, ¼Ò¸ðǰÀÌ Æ÷ÇԵ˴ϴÙ. ½ÄǰÀÇ »ì±Õ-¼Òµ¶ ¿ëµµ´Â ÀÇ·á¿¡ ±¹ÇѵÇÁö ¾Ê°í ½Äǰ ¾ÈÀü ¹× °¡°ø »ê¾÷À¸·Î ½ÃÀå ¹üÀ§¸¦ È®´ëÇÕ´Ï´Ù.

Á¦¾àȸ»ç, º´¿ø, ÀÇ·á±â±â Á¦Á¶¾÷üÀÇ ¾Æ¿ô¼Ò½Ì µ¿ÇâÀº Àü¹® ¸ê±Õ ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ±âȸ¸¦ âÃâÇÏ´Â µ¿½Ã¿¡ ¼­ºñ½º ´Ù¾çÈ­¸¦ ÅëÇØ Àüü ½ÃÀåÀÇ ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

Áö¿ªº° ½ÃÀå ¿ªÇÐ

ºÏ¹Ì´Â ³ôÀº ¼öÁØÀÇ ÀÇ·á ÀÎÇÁ¶ó, ±ÔÁ¦ ¿ä°Ç, ÀÇ·á ½Ã½ºÅÛ Àü¹Ý¿¡ °ÉÃÄ È®¸³µÈ °¨¿° ¹æÁö ÇÁ·ÎÅäÄÝ¿¡ ÈûÀÔ¾î ¿¹Ãø ±â°£ Áß °¡Àå Å« ½ÃÀå Á¡À¯À²À» À¯ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦

È­ÇÐ ¼Òµ¶Á¦ ¾ÈÀü¿¡ ´ëÇÑ ¿ì·Á

Ç¥¸é ¼Òµ¶Á¦, »ì±ÕÁ¦, ¸ê±ÕÁ¦¿¡´Â µ¶¼ºÀÌ ÀÖÀ¸¹Ç·Î È­ÇÐ ¼Òµ¶Á¦ ³ëÃâ·Î ÀÎÇÑ ºÎÀÛ¿ëÀÌ ½ÃÀåÀ» ¾ïÁ¦ÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. Â÷¾Æ¿°¼Ò»ê³ªÆ®·ýÀº Ç÷¾× ¸Å°³ º´¿ø±Õ¿¡´Â È¿°úÀûÀÌÁö¸¸, ºÎ½Ä¼º°ú È£Èí±â ÀڱؼºÀÌ ³ô¾Æ û¼Ò¿øÀ̳ª °Ç¹° °ÅÁÖÀÚ¿¡°Ô À§ÇèÀ» ÃÊ·¡ÇÕ´Ï´Ù.

ƯÈ÷ ȯ°æÀûÀ¸·Î Áö¼Ó°¡´ÉÇÑ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ȯ°æ ¹æÃâ µ¶¼º¿¡ ´ëÇÑ ¿ì·Á·Î ÀÎÇØ ¼Òµ¶Á¦ »ç¿ëÀÌ Á¦Çѵǰí ÀÖ½À´Ï´Ù. ¼Òµ¶Á¦ ¹× »ì±ÕÁ¦¿¡´Â ģȯ°æ ÀÎÁõÀÌ ¾ø±â ¶§¹®¿¡ Á¦Á¶¾÷ü´Â ºÎÆ¿ ÇÁ¸®, pH Áß¼º 4±Þ, °ú»êÈ­¼ö¼Ò ±â¹Ý Á¦Á¦ µî ´ëüǰÀ» °³¹ßÇÏ¿© ½ÃÀå °³¹ßÀÌ Á¦ÇѵǾî ÀÖ½À´Ï´Ù.

°æÀï ±¸µµ

½ÃÀåÀ» ¼±µµÇÏ´Â °ÍÀº 3M, Belimed, Cantel Medical, MMM Group, Sterigenics International LLC, STERIS plc, Matachana Group, Olympus Corporation, Medtronic µî ÀÇ·á±â±â, ¸ê±Õ ½Ã½ºÅÛ, ¼Òµ¶ Á¦Ç°À» Á¦Á¶ÇÏ´Â Áß°ß ±â¾÷ÀÔ´Ï´Ù.

Àü·«Àû ÀÇÀÇ

°¨¿° ¿¹¹æ ½ÃÀåÀº HAI ¿¹¹æ ¿ä°Ç, Àα¸ µ¿Çâ, ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. Çõ½ÅÀûÀÎ Á¦Ç° °³¹ß°ú ȯ°æ ģȭÀûÀÎ ´ëü ¼Ö·ç¼ÇÀ» ÅëÇØ È­ÇÐ ¼Òµ¶Á¦¿Í °ü·ÃµÈ ¾ÈÀü ¹®Á¦¸¦ ÇØ°áÇϸ鼭 °¨¿° ¿¹¹æÀÇ È¿°ú¿Í ȯ°æÀû Áö¼Ó°¡´É¼ºÀÇ ±ÕÇüÀ» ¸ÂÃß´Â °ÍÀÌ ¼º°øÀÇ °ü°ÇÀÔ´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÁÖ¿ä ÀåÁ¡

¾î¶² ¿ëµµ·Î »ç¿ëµÇ´Â°¡?

»ê¾÷ ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¿ªÀû È®Àå, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í ¿µÇâ, ½ÅÁ¦Ç° °³¹ß, °æÀïÀÇ ¿µÇâ

ºÐ¼® ¹üÀ§

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå ½º³À¼ô

Á¦3Àå ºñÁî´Ï½º »óȲ

Á¦4Àå ±â¼ú Àü¸Á

Á¦5Àå ¼¼°èÀÇ °¨¿°Áõ ´ëÃ¥ ½ÃÀå : Á¦Ç°º°

Á¦6Àå ¼¼°èÀÇ °¨¿°Áõ ´ëÃ¥ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚ »ê¾÷º°

Á¦7Àå ¼¼°èÀÇ °¨¿°Áõ ´ëÃ¥ ½ÃÀå : Áö¿ªº°

Á¦8Àå °æÀï ȯ°æ°ú ºÐ¼®

Á¦9Àå ±â¾÷ °³¿ä

Á¦10Àå ºÎ·Ï

µµÇ¥ ¸®½ºÆ®

Ç¥ ¸®½ºÆ®

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Infection Control Market Size:

The global infection control market is expected to grow from USD 50.411 billion in 2025 to USD 62.063 billion in 2030, at a CAGR of 4.25%.

The infection control market encompasses practices and procedures designed to minimize infection and virus transmission risks, particularly in hospitals and healthcare facilities. This market addresses disease prevention from bacteria and viruses that spread through human-to-human contact, contaminated surfaces, and airborne transmission, representing critical healthcare infrastructure for patient safety and facility management.

Market Foundation and Clinical Significance

Infection control practices serve as essential safeguards against hospital-acquired infections (HAIs), which occur during patient facility stays and represent primary mortality causes in healthcare settings. These infections typically result from shared medical equipment usage during diagnostic procedures, leading to conditions including ventilator-associated pneumonia, catheter-associated urinary tract infections, central line-associated bloodstream infections, and surgical-site infections.

HAI development depends on patient immune system status, facility infection control practices, and infectious agent presence within hospital environments. Patient age and extended facility stays contribute significantly to infection risk, while common bacteria associated with HAIs include C. difficile, MRSA, Klebsiella, E. coli, Enterococcus, and Pseudomonas species.

Primary Market Growth Drivers

Hospital-Acquired Infections Prevention

Growing HAI incidence represents the fundamental market driver, as healthcare facilities prioritize sterilization and disinfection practices to prevent patient-to-patient transmission. The most common infections include bloodstream infections, pneumonia, urinary tract infections, and surgical site infections, with surgical site infections representing the largest cost component due to prolonged hospitalization requirements and associated diagnostic testing.

Healthcare facilities implement comprehensive sterilization protocols using advanced equipment and procedures to minimize transmission risks and improve patient outcomes while reducing associated healthcare costs.

Surgical Procedures and Demographic Trends

Increasing surgical procedure volumes coupled with growing geriatric populations and chronic disease prevalence drive sustained market demand. Aging populations demonstrate higher infection susceptibility, requiring enhanced infection control measures and specialized protocols for vulnerable patient populations.

Technological Advancement Integration

Technological improvements in sterilization equipment, including E-beam sterilization and ethylene oxide sterilization reintroduction, support market expansion through enhanced efficacy and efficiency. These advances enable healthcare facilities to implement more effective infection control protocols while addressing diverse sterilization requirements across medical devices and facility surfaces.

Market Segmentation and Applications

The market segments include sterilization services, equipment manufacturing, and consumable products for healthcare facilities, pharmaceutical companies, and medical device manufacturers. Food sterilization and disinfection applications expand market scope beyond healthcare into food safety and processing industries.

Outsourcing trends among pharmaceutical companies, hospitals, and medical device manufacturers create opportunities for specialized sterilization service providers while supporting overall market growth through service diversification.

Geographic Market Dynamics

North America maintains the largest market share during the forecast period, supported by advanced healthcare infrastructure, regulatory requirements, and established infection control protocols across healthcare systems.

Market Constraints and Challenges

Chemical Disinfectant Safety Concerns

Adverse effects from chemical disinfectant exposure present ongoing market constraints due to toxic properties in surface disinfectants, sanitizers, and sterilizers. Sodium hypochlorite, while effective against blood-borne pathogens, demonstrates high corrosiveness and respiratory irritant properties, creating hazards for cleaning personnel and building occupants.

Environmental release toxicity concerns limit disinfectant usage, particularly given increasing demand for environmentally sustainable solutions. The absence of green certification for disinfectants and sterilizers restricts market expansion as manufacturers develop alternatives including butyl-free, pH-neutral quaternary, and hydrogen peroxide-based formulations.

Competitive Landscape

Market leadership includes established companies such as 3M, Belimed, Cantel Medical, MMM Group, Sterigenics International LLC, STERIS plc, Matachana Group, Olympus Corporation, and Medtronic, which manufacture healthcare equipment, sterilization systems, and disinfecting products.

Strategic Implications

The infection control market presents substantial growth opportunities driven by HAI prevention requirements, demographic trends, and technological advancement. Success requires balancing infection control efficacy with environmental sustainability while addressing safety concerns associated with chemical disinfectants through innovative product development and green alternative solutions.

Key Benefits of this Report:

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Global Infection Control Market Segments:

By Products

By End-User Industry

By Geography

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

3. BUSINESS LANDSCAPE

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL INFECTION CONTROL MARKET BY PRODUCTS

6. GLOBAL INFECTION CONTROL MARKET BY END-USER INDUSTRY

7. GLOBAL INFECTION CONTROL MARKET BY GEOGRAPHY

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

9. COMPANY PROFILES

10. APPENDIX

LIST OF FIGURES

LIST OF TABLES

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â